Conditions/Oncologic surgery

CRS & HIPEC

Peritoneal Metastasis, CRS & HIPEC

Two components — not a miracle package for everyone

First question: is complete cytoreduction possible? HIPEC is not automatic.

Cytoreductive surgery (CRS) and HIPEC are related but separate. CRS aims to remove visible peritoneal disease; HIPEC adds heated intraperitoneal chemotherapy in selected protocols afterward. HIPEC is not standard for all peritoneal disease and is not an automatic add-on to every CRS. In colorectal peritoneal metastases, PRODIGE-7 showed no overall-survival benefit for oxaliplatin HIPEC — this must be discussed honestly. PCI score, primary tumor type, fitness, and likelihood of complete cytoreduction decide candidacy. If you are not a candidate, saying so clearly is better than the wrong large operation.

Peritoneal Metastasis, CRS & HIPEC · educational illustration

Educational figures

Tap a figure to enlarge. These English illustrations mirror the Turkish hub gallery for this condition.

  • What it is
  • Candidacy
  • Process
  • Limits
  • CRS ≠ HIPEC

    Clear the disease first; heated chemo is an add-on in selected cases.

  • PRODIGE-7

    Oxaliplatin HIPEC is not a general overall-survival miracle in colorectal PM.

  • Selection

    PCI, primary tumor type, and fitness matter.

  • Honesty

    If you are not a candidate, we say so clearly.

Key points for patients

  • What CRS means
    Tap for details

    Surgical removal of visible peritoneal disease aiming for completeness (CC-0/CC-1). Incomplete cytoreduction rarely justifies maximal morbidity.

  • What HIPEC means
    Tap for details · key note inside
    NoteHIPEC is not standard for everyone.

    Heated intraperitoneal chemotherapy after CRS in selected protocols — not mandatory for every CRS.

  • Evidence boundaries
    Tap for details · key note inside

    In colorectal peritoneal metastases, oxaliplatin HIPEC did not improve overall survival in PRODIGE-7. Other histologies and protocols have different evidence weight.

  • Gastric + extensive peritoneum
    Tap for details · key note inside

    Gastric cancer with extensive peritoneal disease rarely fits a curative HIPEC narrative. Goals must stay realistic.

  • Who is reviewed
    Tap for details

    Patients with limited PCI, favorable biology, and fitness for major surgery are discussed in multidisciplinary settings with complete imaging and prior operative records.

Patient journey

In this hub — follow the pathway step by step. Full Turkish illustrated pages remain linked from each chapter.

Oncologic surgery4 chapters

Appointment / info

Complete imaging and prior operative/pathology records are required for a serious CRS/HIPEC review.

Educational information only; not a substitute for clinical evaluation.

Medical editor: Assoc. Prof. Cengiz Dibekoğlu, MD · English patient-education hub.